Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Photonz’s Chief Scientific Officer Wins NZBIO Award

Photonz’s Chief Scientific Officer Wins NZBIO Award

Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening.

The award is presented to an individual under the age of 40 whose work demonstrates the potential for future leadership in New Zealand’s bioeconomy.

Dr Griffiths won in recognition of his work at Photonz in the development of non-fish eicosapentanoic acid (EPA) produced directly by algal fermentation.

EPA is an increasingly valued ingredient used in the health and pharmaceutical industries. Photonz’s EPA is set to be the first viable replacement source for EPA which otherwise can only be extracted from already-at-risk global fish stocks. Dr Griffiths believes in the positive impact on human and animal health that this product can bring, as well as the environmental advantages of production by fermentation rather than extraction from fish resources.

“Dr Griffiths has made impressive contributions to the New Zealand bio-science community,” said Dr Greg Collier, CEO, Photonz Corp. “Working in the commercial setting of an early stage biotechnology enterprise is challenging enough. But to demonstrate leadership, determination, and remain passionate in his efforts to deliver an ecologically and socially responsible end product, over a seven year span, has amazed us all.”

“I’m honoured to receive this award, and I’m extremely grateful to the talented team at Photonz whose hard work and dedication has supported all the progress that we’ve made,” said Dr Griffiths.

ENDS

About Photonz: Founded in New Zealand in 2002, Photonz Corporation produces the omega-3 fatty acid eicosapentaenoic acid (EPA) which is a critical ingredient in novel therapeutics for the cardiovascular disease market. Photonz has proprietary control over a unique fermentation process involving an EPA-rich strain of marine microalgae. This has been shown to produce EPA in a range of purities up to 97% and to be suited to pharmaceutical applications. Photonz is approaching a commercial-ready phase with facilities in the UK and France involved in late-stage up-scaling of an already proven manufacturing process. EPA, which has a range of food-based and therapeutic applications, is otherwise derived from fish oil.

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Price Of Cheese: Dairy Product Prices Fall To The Lowest This Year

Dairy product prices fell in the latest GlobalDairyTrade auction, hitting the lowest level in the 2015 auctions so far, as prices for milk powder and butter slid amid concern about the outlook for commodities. More>>

ALSO:

Houston, We Have An Air Route: Air New Zealand To Fly Direct To The Heart Of Texas

Air New Zealand will fly its completely refitted Boeing 777-200 aircraft between Auckland and Houston up to five times a week opening up the state of Texas as well as popular nearby tourist states such as Louisiana and Florida. More>>

ALSO:

Scoop Business: Reserve Bank’s Spencer Calls On Govt To Rethink Housing Tax

The Reserve Bank has urged the government to take another look at a capital gains tax on investment in housing, allow increased high-density development and cut red tape for planning consents to address an over-heated Auckland property market. More>>

ALSO:

The Nation: Call For Cross-Party Auckland Housing Plan

Penny Hulse calls for cross-party accord on Auckland housing because “it’s too important to score political points on”. More>>

ALSO:

Flu Season: Overcoming Vaccination Reluctance

While research shows that 40% of New Zealand businesses offer free or subsidised flu vaccinations to employees this time of year, HR professionals say persuading staff to participate is the biggest challenge. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news